ArrowMark Colorado Holdings’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

ArrowMark Colorado Holdings’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-40,000	Closed	-$4.87M	–	369
2020 Q4	$4.87M	Hold	40,000	–	–	0.04%	232
2020 Q3	$3.49M	Hold	40,000	–	–	0.03%	235
2020 Q2	$2.58M	Hold	40,000	–	–	0.03%	220
2020 Q1	$1.79M	Sell	40,000 -20,000	-33%	-$1.06M	0.02%	221
2019 Q4	$3.74M	Hold	60,000	–	–	0.03%	219
2019 Q3	$2.26M	Hold	60,000	–	–	0.02%	217
2019 Q2	$2.44M	Buy	+60,000	New	+$2.14M	0.02%	236

Other funds holding TPTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ArrowMark Colorado Holdings's TPTX Position: Q1 2021 in Review

ArrowMark Colorado Holdings sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q1 2021, closing a stake of 40,000 shares — an estimated $4.87M sold.

ArrowMark Colorado Holdings first reported a position in TPTX in Q2 2019 and held it in 7 quarters. The position peaked at $4.87M in Q4 2020. 202 funds tracked by Wall St. Rank hold TPTX as of Q1 2021.

ArrowMark Colorado Holdings reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
ArrowMark Colorado Holdings sold 40,000 Turning Point Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $4.87M.
ArrowMark Colorado Holdings first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2019 and held it in 7 quarters.
ArrowMark Colorado Holdings's Turning Point Therapeutics, Inc. Common Stock position peaked at $4.87M in Q4 2020.
202 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q1 2021.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2021, filed 17 May 2021.